From Medscape Oncology

Coverage from the

19th World Congress on Gastrointestinal Cancer (WCGC)

June 28 - July 01, 2017; Barcelona, Spain

June 28 - July 01, 2017 Barcelona, Spain
  • WCGC Gastric Cancer Treatment Choice: Look at Tumor Profile In the management of gastric cancer, the choice of second-line therapy with angiogenesis inhibitors or checkpoint inhibitors should be based on individual tumor characteristics, say experts.
  • WCGC Radioembolization 'May Have Role in Locally Advanced HCC' With survival similar to that seen with sorafenib, radioembolization may have a role in treating locally advanced HCC, owing to better quality of life and tumor responses, argue French researchers.

Conference News

Popular News from Last Year’s WCGC

Medscape Oncology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage